Overview

Bortezomib With Steroid Pulse Therapy for Acute Cellular Rejection in Kidney Transplantation

Status:
Unknown status
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether bortezomib is effective in the treatment of acute cellular rejection after kidney transplantation.
Phase:
Phase 3
Details
Lead Sponsor:
Asan Medical Center
Treatments:
Bortezomib
Methylprednisolone